Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Tak Paul Peter, Chief Executive Officer. Officer active across 1 company, notably Candel Therapeutics, Inc.. Cumulatively, 13 reports have been published. Breakdown: 2 buys · 6 sells. Total volume traded: €1.2m. Activity tracked since 29 July 2021. The latest transaction was filed on 25 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Tak Paul Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25,000 shares@ US$8.0012.2% of flowCommon StockSEC:0000899243-21-031097:0
Canonical exit: 27 Oct 2021 (T+90)
13 of 13 declarations
About Tak Paul Peter
Tak Paul Peter is Chief Executive Officer at Candel Therapeutics, Inc. (XNAS). He has 13 filings in total, and in the 13 sampled filings between 2021-08-02 and 2025-06-26, the reported volumes are EUR 173098 on the buy side and EUR 982762 on the sell side, with the modal transaction nature shown as sell.